Shares of Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) rose 899,900% during mid-day trading on Wednesday . The company traded as high as $0.90 and last traded at $0.90. Approximately 188 shares changed hands during trading, a decline of 98% from the average daily volume of 8,016 shares. The stock had previously closed at $0.00.
Orgenesis Stock Performance
The stock has a 50-day simple moving average of $1.54 and a 200-day simple moving average of $2.03.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Recommended Stories
- Five stocks we like better than Orgenesis
- Trading Stocks: RSI and Why it’s Useful
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- How Marvell Went From Short Target to Breakout Star
- ESG Stocks, What Investors Should Know
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
